ArticleIrish journal of medical science2026
The clinical significance of the naples prognostic score in adult idiopathic nephrotic syndrome: a retrospective study.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNephrotic syndrome (NS) is characterized by heavy proteinuria, hypoalbuminemia, and edema due to glomerular filtration barrier damage. While NS is classified as steroid-sensitive (SSNS) or steroid-resistant (SRNS), the role of inflammatory and nutritional biomarkers in predicting disease severity remains understudied. Naples Prognostic Score (NPS), combining serum albumin, cholesterol, neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR), has prognostic value in inflammatory diseases, but its role in NS is unclear.
objectiveThis study evaluated NPS in adult idiopathic nephrotic syndrome (AINS) to assess its relationship with disease severity, progression, and inflammatory/nutritional status.
methodsA retrospective analysis included 248 adult NS patients from 2015-2025. After excluding 54 with secondary causes, 194 patients with idiopathic NS were analyzed. Demographic, biochemical, hematologic, proteinuria, and kidney function data were collected. NPS was calculated and stratified into two groups: 1-2 and 3-4. Spearman's correlation examined associations with clinical parameters.
resultsPatients with NPS 3-4 had higher creatinine and neutrophil counts (p < 0.001) and lower lymphocyte counts (p < 0.001) than those with NPS 1-2. NPS negatively correlated with lymphocytes (ρ = - 0.544) and cholesterol (ρ = - 0.392), and positively with neutrophils (ρ = 0.341) and creatinine (ρ = 0.263), all p < 0.001. These results indicate that NPS reflects inflammatory status and associates with kidney function.
conclusionNPS is a promising biomarker for assessing inflammation, nutritional status, and disease severity in AINS. Prospective, multi-center studies are needed to validate its clinical utility and potential role in guiding individualized NS treatment.
Indexed as
Identifiers
42671753What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.